Conjugates of an active agent attached to a targeting moiety, such as at least one HSP90 binding moiety, via a linker, have been designed. Such conjugates can provide improved temporospatial delivery of the active agent, improved biodistribution and penetration in tumor, and/or decreased toxicity. Methods of making the conjugates and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer.
将附着到靶向基团上的活性药剂的共轭物,例如至少一个HSP90结合基团,通过连接剂设计。这样的共轭物可以提供改善的活性药剂的时间空间传递,改善在肿瘤中的
生物分布和渗透,以及/或减少毒性。提供了制备这些共轭物和其配方的方法。提供了将这些配方用于需要的受试者的方法,例如用于治疗或预防癌症。